FINELINE II Sterox: payments to doctors
Payments that named FINELINE II Sterox as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $34K
- Providers
- 183
- Transactions
- 308
- Average per transaction
- $110
The per-transaction average — $110 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 183 providers the average total is $185, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Boston Scientific | $33,901 | 100.0% |